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Summary. The present review deals with the anatomical 
distribution, physiological importance, and pathological 
implications of the neuronal-type nitric oxide synthase 
(nNOS) in skeletal muscle. Throughout the body, nNOS 
is located beneath the sarcolemma of skeletal muscle 
fibers. In rodents, nNOS is enriched in type IIb muscle 
fibers, but is more homogenously distributed among type 
I1 and type I fibers in humans and subhuman primates. It 
is accumulated on the postsynaptic membrane at the 
neuromuscular junction. An increased concentration of 
nNOS is noted at the sarcolemma of muscle spindle 
fibers, in particular nuclear bag fibers, which belong to 
type I fibers.  The association of nNOS with the 
sarcolemma is mediated by the dystrophin-g1 ycoprotein 
complex. Specifically, nNOS is linked to al-syntrophin 
through PDZ domain interactions. Possibly, it also 
directly binds to dystrophin. The activity and expression 
of nNOS are regulated by both myogenic and neurogenic 
factors. Besides acetylcholine, glutamate has also been 
shown to stimulate nNOS, probably acting through N- 
methyl-D-aspartate receptors, which are colocalized with 
nNOS at the junctional sarcolemma. Functional studies 
have implicated nitric oxide as a modulator of skeletal 
muscle contractility, mitochondrial respiration, carbo- 
hydrate metabolism, and neuromuscular transmission. A 
clinically relevant aspect of nNOS is its absence from 
the skeletal muscle sarcolemma of patients with 
Duchenne muscular dystrophy (DMD). A concept is 
presented which suggests that, as a consequence of the 
disruption of the dystrophin-glyoprotein complex in 
DMD, nNOS fails to become attached to the sarcolemma 
and is subject to downregulation in the cytosol. 
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Introduction 
Since the discovery that the biological activity of the 
endothelium-derived relaxing factor is due to the 
synthesis and release of the free radical nitric oxide 
(NO) (Ignarro et al., 1987; Palmer et al., 1987), an 
impressive body of evidence has been produced 
unravelling NO as a multifunctional messenger which is 
involved in a wide range of physiological processes, 
such as  as the control of vascular resistance, the 
regulation of blood fluidity, immune response to 
invading pathogens and tumor cells, the synaptic 
transmission and modulation as well as the relaxation of 
smooth muscle in the wall of visceral organs. NO is 
formed intracellularly by the action of NO synthase 
(NOS; EC 1.14.13.39), an iron protoporphyrin IX 
(heme)- and flavin-containing oxidoreductase, which 
catalyzes a five electron oxidation of a guanidino- 
nitrogen of L-arginine to yield NO and L-citrulline. 
Three isoforms of NOS have been identified which share 
common catalytic properties, but otherwise differ with 
respect to their chromosomal localization, cellular 
expression, and molecular regulation. The neuronal 
(nNOS) and endothelial (eNOS) isoforms are 
constitutive and dependent on ~ a ~ + / c a l m o d u l i n .  The 
inducible NOS (iNOS) is regulated at the transcriptional 
level by numerous agents generated during an immune 
or inflammatory reaction. As NO is a readily diffusible, 
short-lived agent which, on the basis of its physico- 
chemical properties, is able to interact with an array of 
molecular targets in- and outside the cells, advances in 
our knowledge of the biological actions of NO are 
derived to a large extent from studies using inhibitors of 
NOS or, more recently, targeted disruption of the genes 
encoding for the NOS isoenzymes (Huang and Fishman, 
1996). Comprehensive review articles and multi- 
authored books are available containing in-depth 
discussions of the various aspects of NO function, and 
the reader is referred to these sources for detailed 
information (e.g., Moncada et al., 1991; Nathan, 1992; 
Moncada and Higgs, 1993; Bredt and Snyder, 1994; 













